成人2型糖尿病基础胰岛素起始调量期专家指导意见

2021-10-15 中国内分泌相关专家小组(统称) 中国糖尿病杂志

糖尿病是一种慢性进展性疾病,长期慢性高血糖可显著增加糖尿病患者慢性并发症发生的风险。多项研究均已证实,持续良好的血糖控制可减少糖尿病慢性并发症发生风险。

中文标题:

成人2型糖尿病基础胰岛素起始调量期专家指导意见

发布日期:

2021-10-15

简要介绍:

糖尿病是一种慢性进展性疾病,长期慢性高血糖可显著增加糖尿病患者慢性并发症发生的风险。多项研究均已证实,持续良好的血糖控制可减少糖尿病慢性并发症发生风险。当前我国2型糖尿病(T2DM)的管理现况是血糖控制水平差,口服降糖药(OAD)联合胰岛素治疗的T2DM患者中仅26%~38%的患者糖化血红蛋白(HbA1c)达标(HbA1c<7%)。导致这一现状与胰岛素治疗不规范相关。接受生活方式干预或OAD治疗血糖控制不达标的T2DM患者中,超过半数患者治疗过程中存在临床惰性,表现为胰岛素治疗起始偏晚,及起始胰岛素治疗后的剂量调整不足导致胰岛素治疗剂量偏低、血糖控制不理想。

相关资料下载:
[AttachmentFileName(sort=1, fileName=成人2型糖尿病基础胰岛素起始调量期专家指导意见.pdf)] GetToolGuiderByIdResponse(projectId=1, id=410681c0022613a4, title=成人2型糖尿病基础胰岛素起始调量期专家指导意见, enTitle=, guiderFrom=中国糖尿病杂志, authorId=0, author=, summary=糖尿病是一种慢性进展性疾病,长期慢性高血糖可显著增加糖尿病患者慢性并发症发生的风险。多项研究均已证实,持续良好的血糖控制可减少糖尿病慢性并发症发生风险。, cover=https://img.medsci.cn/20211112/1636706664313_5579292.jpg, journalId=0, articlesId=null, associationId=666, associationName=中国内分泌相关专家小组(统称), associationIntro=这是一个统称,其下指南和专家共识均由国内内分泌领域的专家制定。, copyright=0, guiderPublishedTime=Fri Oct 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>糖尿病是一种慢性进展性疾病,长期慢性高血糖可显著增加糖尿病患者慢性并发症发生的风险。多项研究均已证实,持续良好的血糖控制可减少糖尿病慢性并发症发生风险。当前我国2型糖尿病(T2DM)的管理现况是血糖控制水平差,口服降糖药(OAD)联合胰岛素治疗的T2DM患者中仅26%~38%的患者糖化血红蛋白(HbA1c)达标(HbA1c<7%)。导致这一现状与胰岛素治疗不规范相关。接受生活方式干预或OAD治疗血糖控制不达标的T2DM患者中,超过半数患者治疗过程中存在临床惰性,表现为胰岛素治疗起始偏晚,及起始胰岛素治疗后的剂量调整不足导致胰岛素治疗剂量偏低、血糖控制不理想。</p>, tagList=[TagDto(tagId=216, tagName=糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=77348, appHits=472, showAppHits=0, pcHits=518, showPcHits=76874, likes=0, shares=66, comments=13, approvalStatus=1, publishedTime=Tue Nov 16 23:57:33 CST 2021, publishedTimeString=2021-10-15, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Nov 12 17:43:10 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 04:47:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=成人2型糖尿病基础胰岛素起始调量期专家指导意见.pdf)])
成人2型糖尿病基础胰岛素起始调量期专家指导意见.pdf
下载请点击:
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1201375, encodeId=6bc912013e56b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98a06500104, createdName=ms4000001694579706, createdTime=Thu Mar 10 15:01:22 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199498, encodeId=de2311994984f, content=可以给与一定参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6033081957, createdName=865000496, createdTime=Fri Mar 04 22:37:32 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194656, encodeId=a5a8119465671, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:15 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187118, encodeId=86f6118e11837, content=实用,精简。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sat Jan 22 09:28:59 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082563, encodeId=888d1082563b0, content=真的可以 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a075617739, createdName=杨云姣, createdTime=Tue Dec 21 14:23:22 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-03-10 ms4000001694579706

    非常有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1201375, encodeId=6bc912013e56b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98a06500104, createdName=ms4000001694579706, createdTime=Thu Mar 10 15:01:22 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199498, encodeId=de2311994984f, content=可以给与一定参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6033081957, createdName=865000496, createdTime=Fri Mar 04 22:37:32 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194656, encodeId=a5a8119465671, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:15 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187118, encodeId=86f6118e11837, content=实用,精简。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sat Jan 22 09:28:59 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082563, encodeId=888d1082563b0, content=真的可以 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a075617739, createdName=杨云姣, createdTime=Tue Dec 21 14:23:22 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-03-04 865000496

    可以给与一定参考

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1201375, encodeId=6bc912013e56b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98a06500104, createdName=ms4000001694579706, createdTime=Thu Mar 10 15:01:22 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199498, encodeId=de2311994984f, content=可以给与一定参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6033081957, createdName=865000496, createdTime=Fri Mar 04 22:37:32 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194656, encodeId=a5a8119465671, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:15 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187118, encodeId=86f6118e11837, content=实用,精简。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sat Jan 22 09:28:59 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082563, encodeId=888d1082563b0, content=真的可以 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a075617739, createdName=杨云姣, createdTime=Tue Dec 21 14:23:22 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-02-18 1351fc2f66m

    看看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1201375, encodeId=6bc912013e56b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98a06500104, createdName=ms4000001694579706, createdTime=Thu Mar 10 15:01:22 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199498, encodeId=de2311994984f, content=可以给与一定参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6033081957, createdName=865000496, createdTime=Fri Mar 04 22:37:32 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194656, encodeId=a5a8119465671, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:15 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187118, encodeId=86f6118e11837, content=实用,精简。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sat Jan 22 09:28:59 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082563, encodeId=888d1082563b0, content=真的可以 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a075617739, createdName=杨云姣, createdTime=Tue Dec 21 14:23:22 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-01-22 annie5685

    实用,精简。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1201375, encodeId=6bc912013e56b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98a06500104, createdName=ms4000001694579706, createdTime=Thu Mar 10 15:01:22 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199498, encodeId=de2311994984f, content=可以给与一定参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6033081957, createdName=865000496, createdTime=Fri Mar 04 22:37:32 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194656, encodeId=a5a8119465671, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:15 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187118, encodeId=86f6118e11837, content=实用,精简。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sat Jan 22 09:28:59 CST 2022, time=2022-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082563, encodeId=888d1082563b0, content=真的可以 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a075617739, createdName=杨云姣, createdTime=Tue Dec 21 14:23:22 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2021-12-21 杨云姣

    真的可以

    0

拓展阅读

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA(POA)糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 (2010年)

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01